Acute onset paraneoplastic cerebellar degeneration in a patient with small cell lung cancer

Neurology India

Volumn 51, Issue 2, 2003, Pages 244-245

  Bhatia, Rohit ^a   Prabhakar, S ^a   Lal, V ^a   Khurana, D ^a   Das, C P ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Cerebellar degeneration; Paraneoplastic neurological syndromes

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; ATAXIA; BIOCHEMISTRY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; CELL COUNT; CEREBROSPINAL FLUID ANALYSIS; DYSMETRIA; HOSPITAL ADMISSION; HUMAN; LUNG CARCINOMA; LUNG EMPHYSEMA; LUNG SMALL CELL CANCER; MALE; MULTIMODALITY CANCER THERAPY; NYSTAGMUS; PARANEOPLASTIC NEUROPATHY; SLURRED SPEECH;

CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PARANEOPLASTIC CEREBELLAR DEGENERATION; RADIOGRAPHY, THORACIC; THORACOTOMY;

EID: 0242442099     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Posner JB. Paraneoplastic syndrome involving the nervous system. In: Aminoff MJ, editor. Neurology and General Medicine. New York: Churchill Livingstone; pp. 401-20.
2. Cher LM, Henson JW, Das A, Hochberg FH. Paraneoplastic syndromes. In: Aminoff MJ, Goetz CG, editors. Handbook of Clinical Neurology. Systemic Diseases, Part III, Elsevier Science. B.V; 1998. Vol 27. pp. 673-704.
3. Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol 1999;56:405-8.
4. Dalmau JO, Furnoux HM, Rosenblum MK, Graus F, Posner JB. Detection of the anti-Hu antibody in specific regions of nervous system and tumor from the patients with paraneoplastic encephalomyelitis/sensory neuronopathy. Neurology 1991;41:1757-64.
5. Hammack JE, Posner JB. Paraneoplastic cerebellar degeneration. In: Platakis A, editor. Cerebellar Degeneration. Clinical Neurobiology. Kluwer: Boston; 1992;475-9.
6. Croft PB, Wilkinson M. The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 1965;88:427-34.
7. Graus F, Dalmau J, Vallderoriola F, et al. Immunological characterization of a neuronal antibody (anti-Tv) associated with paraneoplastic cerebellar degeneration and Hodgkin's disease. J Neuroimmunol 1997;74:55-61.
8. Posner JB. Paraneoplastic syndromes. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in Clinical Practice. Boston: Butterworth Heinemann; pp. 1299-308.
9. Henson RA, Urich H. Cortical cerebellar degeneration. In: Cancer and Nervous System. Oxford: Blackwell Scientific; 1982. pp. 346-67.
10. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: A clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc 1998;65:1423-31.
11. Peterson K, Rosenblum MK, Kotanidws H, Posner JB. Paraneoplastic cerebellar degeneration: A clinical analysis of 55 anti-Yo antibody positive patients. Neurology 1992;42:1931-7.
12. Dvopcho EJ. Autoimmune CNS paraneoplastic disorders: Mechanisms, diagnosis and therapeutic options. Ann Neur 1995;37(Suppl):S102-13.
13. Anderson NE, Rosenblum MK, Posner JB. Paraneoplastic cerebellar degeneration: Clinical immunological correlations. Ann Neurol 1988;24:559-67.
14. Moll JW, Antoine JC, Bzashear HR, et al. Guidelines on the detection of paraneoplastic antineuronal specific antibodies. Neurology 1995;45:1937-41.
15. Albert ML, Austin LM, Darnell RB. Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration. Ann Neurol 2000;47:9-17.
16. Verschuuven J, Chuang L, Rosenblum MK, et al. Inflammatory infiltrates and complete absence of Purkinje cells in anti-Yo associated paraneoplastic cerebellar degeneration. Acta Neuropathol 1996;91:519-25.